There have been reported cases of life-threatening, sometimes fatal pancreatitis associated with the use of BLINCYTO (blinatumomab) in clinical trial and post-market settings.
Hazard description
Product safety
Get notified of similar recallsEnter your email to receive alerts when new recalls are issued by the same agency.
Subscribed. You'll get an email when new recalls are issued.
RecallTracker